384 related articles for article (PubMed ID: 19916268)
1. Outwitting HIV: Minnesota researchers take on a clever virus.
Bell H
Minn Med; 2009 Oct; 92(10):22-6. PubMed ID: 19916268
[No Abstract] [Full Text] [Related]
2. Adenovirus as vector for HIV: efficacy and safety issues.
Natuk RJ; Wade MS; Chengalvala M; Murthy KK; Chanda PK; Murthy SC; Bhat BM; Bhat R; Dheer SK; Mizutani S
Dev Biol Stand; 1995; 84():153-6. PubMed ID: 7796948
[No Abstract] [Full Text] [Related]
3. AIDS vaccine test to be expanded based on upbeat results.
AIDS Read; 2005 Nov; 15(11):561, 573. PubMed ID: 16329176
[No Abstract] [Full Text] [Related]
4. HIV/AIDS. Hedged bet: an unusual AIDS vaccine trial.
Cohen J
Science; 2005 Aug; 309(5737):1003. PubMed ID: 16099960
[No Abstract] [Full Text] [Related]
5. [Prospects for vaccine development against HIV infection].
Kurth R; Binninger D; Ennen J; Denner J; Hartung S; Norley S
Verh Dtsch Ges Inn Med; 1991; 97():394-402. PubMed ID: 1808921
[No Abstract] [Full Text] [Related]
6. HIV-1 therapeutic vaccines.
Kinloch-de Loes S; Autran B
J Infect; 2002 Apr; 44(3):152-9. PubMed ID: 12099741
[TBL] [Abstract][Full Text] [Related]
7. New strategies to combat HIV: augmenting antiviral immunity.
Smith KA; Boyle BA
AIDS Read; 2003 Aug; 13(8):365-9, 382. PubMed ID: 14524321
[No Abstract] [Full Text] [Related]
8. Assessment of mucosal immunity to HIV-1.
Jespers V; Harandi AM; Hinkula J; Medaglini D; Le Grand R; Stahl-Hennig C; Bogers W; El Habib R; Wegmann F; Fraser C; Cranage M; Shattock RJ; Spetz AL
Expert Rev Vaccines; 2010 Apr; 9(4):381-94. PubMed ID: 20370549
[TBL] [Abstract][Full Text] [Related]
9. [Protective mucosal immunity and HIV-1 mucosal vaccine strategy].
Huang Y; Huang XG; Xu JQ
Bing Du Xue Bao; 2009 Jul; 25(4):318-22. PubMed ID: 19769168
[No Abstract] [Full Text] [Related]
10. Immunisation with gp160 in HIV-1 infection.
Pontesilli O; Aiuti F
Lancet; 1999 Sep; 354(9182):948-9. PubMed ID: 10489977
[No Abstract] [Full Text] [Related]
11. HIV/AIDS: allied responses.
Mascola JR
Nature; 2007 Sep; 449(7158):29-30. PubMed ID: 17805280
[No Abstract] [Full Text] [Related]
12. [Pathogenesis of HIV infection as the key to eradication? New therapeutic approaches].
Manegold C
MMW Fortschr Med; 2000 Mar; 142 Suppl 1():34-9. PubMed ID: 10863308
[TBL] [Abstract][Full Text] [Related]
13. [Development of a vaccine against HIV: is this aim accomplishable?].
Wagner R; Asbach B
MMW Fortschr Med; 2013 Jun; 155 Suppl 1():36-9. PubMed ID: 23961653
[No Abstract] [Full Text] [Related]
14. Retrovirus meeting. HIV/AIDS researchers reach for high-hanging fruit.
Cohen J
Science; 2009 Feb; 323(5917):996-7. PubMed ID: 19229005
[No Abstract] [Full Text] [Related]
15. Mucosally-targeted HIV-1 vaccines.
Wegmann F
Hum Vaccin; 2011 Sep; 7(9):982-5. PubMed ID: 21892008
[No Abstract] [Full Text] [Related]
16. Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine.
Belyakov IM; Ahlers JD
Trends Immunol; 2008 Nov; 29(11):574-85. PubMed ID: 18838298
[TBL] [Abstract][Full Text] [Related]
17. HIV vaccine efficacy trials: towards the future of HIV prevention.
Kim D; Elizaga M; Duerr A
Infect Dis Clin North Am; 2007 Mar; 21(1):201-17, x. PubMed ID: 17502236
[TBL] [Abstract][Full Text] [Related]
18. Clinical research. A setback and an advance on the AIDS vaccine front.
Cohen J
Science; 2003 Apr; 300(5616):28-9. PubMed ID: 12677027
[No Abstract] [Full Text] [Related]
19. Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites.
Mestecky J
J Reprod Immunol; 2006 Dec; 72(1-2):1-17. PubMed ID: 17095369
[TBL] [Abstract][Full Text] [Related]
20. Cure of HIV infection: is the long wait over?
Shearer WT
J Allergy Clin Immunol; 2014 Jul; 134(1):20-2. PubMed ID: 25117800
[No Abstract] [Full Text] [Related]
[Next] [New Search]
